Personalized Oncology Market to Reach USD 18.4 Billion by 2035 | AI, Genomics, Liquid Biopsy & Precision Medicine Driving Growth Across the U.S., Germany, UK, Japan & India
Market Overview The Personalized Oncology Market is experiencing significant growth as precision medicine, genomic profiling, biomarker testing, and artificial intelligence (AI) reshape cancer diagnosis and treatment. Personalized oncology focuses on tailoring therapies based on a patient's genetic profile, tumor biomarkers, and molecular characteristics, enabling more effective treatments with improved clinical outcomes and reduced adverse effects. The increasing adoption of companion diagnostics, targeted therapies, immunotherapies, and next-generation sequencing (NGS) is accelerating the transition toward individualized cancer care. According to MarketGenics , the global Personalized Oncology Market is projected to grow from USD 7.7 Billion in 2025 to USD 18.4 Billion by 2035 , registering a CAGR of 9.1% during the forecast period. Rising investments in oncology research, precision medicine initiatives, AI-driven cancer diagnostics, and genomic sequencing technologies ...